This new two-level motion correction approach provides superior performance compared with other tracking systems. DualTrac offers fast, reliable results for accurate diagnosis and follow-up.
Harlow, Essex (PRWEB UK) 11 November 2016
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard optometry and ophthalmic equipment, is pleased to announce the official UK launch of DualTrac Motion Correction technology on the AngioVue OCT-A and Vault Mapping software on Optovue’s iSeries OCT systems (iVue, iFusion and iScan).
DualTrac Motion Correction is a unique technology which provides motion correction at two levels. It combines video tracking and Motion Correction Technology (MCT) to enable true 3D tracking. The first level provides real-time correction for rapid eye movements, blinking or eye drifting, which improves patient comfort. The second level occurs during post-processing of imaging and corrects smaller levels of motion distortion. This combined approach results in reliable motion correction for patients who have trouble directing their focus on a central point during an eye exam and is essential for high-quality OCT-A imaging.
Jacqui Kenyon, HS-UK Product Manager, said, “This new two-level motion correction approach provides superior performance compared with other tracking systems. DualTrac offers fast, reliable results for accurate diagnosis and follow-up.”
The Vault Mapping tool is available exclusively on Optovue’s iVue, iFusion and iScan OCT systems. It enables precise visualisation of the lens-to-eye relationship for specialty lens fitting. The vault map report allows the user to evaluate central corneal clearance in exact microns. Lens settling can also be measured between the first and second scan with the change map, and an anterior display report allows evaluation of superior, temporal, inferior and nasal landing zones.
For more information on any of the Optovue OCT and OCT-A range of products, please call Haag-Streit UK on (01279) 883807, or email info(at)haag-streit-uk.com.